Turning Point Therapeutics to Participate in Guggenheim Oncology Day
SAN DIEGO, Feb. 03, 2020 (GLOBE NEWSWIRE) -- Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a precision oncology company developing next-generation therapies that target genetic drivers of cancer, today announced that President and CEO Athena …